Ceftazidime/avibactam
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Complicated intra-abdominal infection (cIAI) in combination with metronidazole
- Complicated urinary tract infection (cUTI) including pyelonephritis
NON-FDA APPROVED USES
- Resistant Gram-negative infections including ESBL-producing and certain carbapenemase-producing (KPC only) bacteria
- Trials are currently underway for the management of hospital-acquired and/or ventilator-associated pneumonia
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Complicated intra-abdominal infection (cIAI) in combination with metronidazole
- Complicated urinary tract infection (cUTI) including pyelonephritis
NON-FDA APPROVED USES
- Resistant Gram-negative infections including ESBL-producing and certain carbapenemase-producing (KPC only) bacteria
- Trials are currently underway for the management of hospital-acquired and/or ventilator-associated pneumonia
There's more to see -- the rest of this entry is available only to subscribers.